-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, GGrKr8cKqlnWlExIRiOZ042jMKKo02v30jH58jxICT6LEU5NleE5zxCLDfZ9lY87 0NMr3z/YMA2XlE/v5zM5jw== 0001225208-09-021514.txt : 20091103 0001225208-09-021514.hdr.sgml : 20091103 20091103163754 ACCESSION NUMBER: 0001225208-09-021514 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20091030 FILED AS OF DATE: 20091103 DATE AS OF CHANGE: 20091103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: READ IAN C CENTRAL INDEX KEY: 0001372915 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-03619 FILM NUMBER: 091154924 MAIL ADDRESS: STREET 1: PFIZER INC ATTN CORPORATE SECRETARY STREET 2: 235 EAST 42ND STREET CITY: NEW YORK STATE: NY ZIP: 10017 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PFIZER INC CENTRAL INDEX KEY: 0000078003 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 135315170 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 235 E 42ND ST CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 2125732323 MAIL ADDRESS: STREET 1: 235 E 42ND ST CITY: NEW YORK STATE: NY ZIP: 10017 FORMER COMPANY: FORMER CONFORMED NAME: PFIZER CHARLES & CO INC DATE OF NAME CHANGE: 19710908 4 1 doc4.xml X0303 4 2009-10-30 0000078003 PFIZER INC PFE 0001372915 READ IAN C PFIZER INC. ATT: CORPORATE SECRETARY 235 EAST 42ND STREET NEW YORK NY 10017 1 Senior Vice President Common Stock 2009-10-30 4 A 0 14680 0 A 471534 D Common Stock 5809 I By Rule 16b-3 Plan Phantom Stock Units SSP 0 2009-10-30 4 A 0 290 17.03 A Common Stock 290 64981 D Stock Appreciation Rights 17.03 2009-10-30 4 A 0 54585 0 A 2014-10-30 2014-10-30 Common Stock 54585 54585 D The reported transaction constitutes the grant of restricted stock units, which will vest and be settled in shares of Pfizer common stock on the third anniversary of the date of grant, provided that the reporting person remains in the continuous employ of Pfizer until that anniversary date. Each unit represents one phantom share of common stock. These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. The stock appreciation rights will vest on the third anniversary of the date of grant, provided that the reporting person remains in the continuous employ of Pfizer until that anniversary date, and will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. Lawrence A. Fox, by power of atty. 2009-11-03 -----END PRIVACY-ENHANCED MESSAGE-----